Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review

被引:35
|
作者
Ivanova, T. [1 ]
Jalil, A. [1 ]
Antoniou, Y. [1 ]
Bishop, P. N. [1 ,2 ]
Vallejo-Garcia, J. L. [1 ,3 ]
Patton, N. [1 ]
机构
[1] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester Acad Hlth Sci Ctr, Oxford Rd, Manchester M13 9WH, Lancs, England
[2] Univ Manchester, Inst Human Dev, Ctr Ophthalmol & Vis Sci, Manchester, Lancs, England
[3] Humanitas Clin Res Ctr, Rozzano Milan, Italy
关键词
PARS-PLANA VITRECTOMY; RHEGMATOGENOUS RETINAL-DETACHMENT; Q-SWITCHED NEODYMIUM; MACULAR HOLE; FLOATERS; SAFETY; VITREOLYSIS; 20-GAUGE; SURGERY; ORGANIZATION;
D O I
10.1038/eye.2016.30
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Floaters are a common ocular condition which form as a consequence of aging changes in the vitreous. Although in most patients the symptoms are minimal, they can cause significant impairment in vision-related quality of life in a small population of patients. Recently there has been an increase in awareness of the visual disability caused by floaters, and the evidence-base for treatment of this condition using small-gauge vitrectomy has increased. In this review, we define the term 'floaters' as symptomatic vitreous opacities (SVO). We suggest a classification dependent on the presence or absence of posterior vitreous detachment and discuss their pathogenesis and natural history. We review their impact on patients' quality of life related to visual function. We review the psychological factors that may have a role in some patients who appear to be affected by SVO to the extent that they pursue all options including surgery with all its attendant risks. We summarise the available evidence-base of treatment options available for SVO with special emphasis on the safety and efficacy of vitrectomy for this condition.
引用
收藏
页码:645 / 655
页数:11
相关论文
共 50 条
  • [1] Current treatment strategies for symptomatic vitreous opacities
    Ryan, Edwin H.
    CURRENT OPINION IN OPHTHALMOLOGY, 2021, 32 (03) : 198 - 202
  • [2] Reading Speed as an Objective Measure of Improvement Following Vitrectomy for Symptomatic Vitreous Opacities
    Ryan, Edwin H.
    Lam, Linda A.
    Pulido, Christine M.
    Bennett, Steven R.
    Calabrese, Aurelie
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2020, 51 (08) : 456 - 466
  • [3] Return to the Operating Room after Vitrectomy for Vitreous Opacities Intelligent Research in Sight Registry Analysis
    Rubino, Shaina M.
    Parke, D. Wilkin, III
    Lum, Flora
    OPHTHALMOLOGY RETINA, 2021, 5 (01): : 4 - 8
  • [4] Pars plana vitrectomy for persistent, visually significant vitreous opacities
    Schiff, WM
    Chang, S
    Mandava, N
    Barile, GR
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2000, 20 (06): : 591 - 596
  • [5] YAG laser vitreolysis for treatment of symptomatic vitreous opacities
    Brasse, K.
    Schmitz-Valckenberg, S.
    Juenemann, A.
    Roider, J.
    Hoerauf, H.
    OPHTHALMOLOGE, 2019, 116 (01): : 73 - 84
  • [6] Results of vitrectomy in rhegmatogenous retinal detachment and dense vitreous opacities
    Hoerauf, H
    Roider, J
    Herboth, T
    Hager, A
    Laqua, H
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1997, 211 (06) : 369 - 374
  • [7] Symptomatic Vitreous Opacities: Exploring the Mismatch between Clinical Observation of Vitreous Alterations and Self-Reported Symptoms
    Bamonte, Giulio
    Iodice, Clemente Maria
    Mastropasqua, Rodolfo
    Van Dijk, Elon H. C.
    Appeltans, Andrea
    Cicinelli, Maria Vittoria
    Menean, Matteo
    Ten Tusscher, Marcel
    Harmer, Stuart W.
    Marolo, Paola
    Borrelli, Enrico
    Reibaldi, Michele
    Panos, Georgios D.
    Motta, Lorenzo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [8] SAFETY, EFFICACY, AND QUALITY OF LIFE FOLLOWING SUTURELESS VITRECTOMY FOR SYMPTOMATIC VITREOUS FLOATERS
    Mason, John O., III
    Neimkin, Michael G.
    Mason, John O.
    Friedman, Duncan A.
    Feist, Richard M.
    Thomley, Martin L.
    Albert, Michael A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (06): : 1055 - 1061
  • [9] Treatment of Symptomatic Vitreous Opacities with Pharmacologic Vitreolysis Using a Mixure of Bromelain, Papain and Ficin Supplement
    Takeuchi, Masaru
    Shieh, Po-Chuen
    Horng, Chi-Ting
    APPLIED SCIENCES-BASEL, 2020, 10 (17):
  • [10] Subcutaneous Immunoglobulin for Primary and Secondary Immunodeficiencies: an Evidence-Based Review
    Lingman-Framme, Jenny
    Fasth, Anders
    DRUGS, 2013, 73 (12) : 1307 - 1319